Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pilz

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2010
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatmentP Wipfler, K Oppermann, G Pilz, et al.
Clinical and Experimental Immunology|January 22, 2015
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosisA Harrer, G Pilz, P Wipfler, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 18, 2025
Seminars in epileptology: How to diagnose status epilepticus in adults and childrenM Leitinger, P Bosque-Varela, G Kuchukhidze, et al.
Frontiers in Neurology|October 17, 2022
Malnutrition risk and oropharyngeal dysphagia in the chronic post-stroke phaseV A L Huppertz, W Pilz, G Pilz Da Cunha, et al.
Acta Neurologica Scandinavica|January 4, 2012
Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsyE Broussalis, M Hutterer, K Oppermann, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 15, 2015
2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR RegistryO Bruder, S Schneider, G Pilz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2010
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatmentP Wipfler, K Oppermann, G Pilz, et al.
Clinical and Experimental Immunology|January 22, 2015
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosisA Harrer, G Pilz, P Wipfler, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 18, 2025
Seminars in epileptology: How to diagnose status epilepticus in adults and childrenM Leitinger, P Bosque-Varela, G Kuchukhidze, et al.
Frontiers in Neurology|October 17, 2022
Malnutrition risk and oropharyngeal dysphagia in the chronic post-stroke phaseV A L Huppertz, W Pilz, G Pilz Da Cunha, et al.
Acta Neurologica Scandinavica|January 4, 2012
Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsyE Broussalis, M Hutterer, K Oppermann, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 15, 2015
2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR RegistryO Bruder, S Schneider, G Pilz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
Pageof 8